NCT05772507View on ClinicalTrials.gov

Efficacy and Tolerance of URGO AWC_008 and URGO AWC_022 Dressings (EXPANSION)

NAUnknownINTERVENTIONAL

Enrollment

85

Participants

Timeline

Start Date

August 22, 2023

Primary Completion Date

July 31, 2024

Study Completion Date

October 31, 2024

Conditions

Diabetic Foot UlcerVenous Leg UlcerPressure UlcerWound InfectionAcute Wounds

Interventions

DEVICE

URGO AWC_008 dressing or URGO AWC_022 dressing

local management of acute or chronic wounds

Trial Locations (1)

Unknown

RECRUITING

URGO, Dijon

Sponsors

Lead Sponsor

Laboratoires URGO

All Listed Sponsors

lead

Laboratoires URGO

INDUSTRY

NCT05772507 - Efficacy and Tolerance of URGO AWC_008 and URGO AWC_022 Dressings (EXPANSION) | Biotech Hunter | Biotech Hunter